SCMP
Sucampo Pharmaceuticals, Inc.
SCMP
SCMP
Delisted
SCMP was delisted on the 12th of February, 2018.
167 hedge funds and large institutions have $287M invested in Sucampo Pharmaceuticals, Inc. in 2017 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 57 increasing their positions, 47 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
167
Holders Change
+2
Holders Change %
+1.21%
% of All Funds
4.16%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
40
Increased
57
Reduced
47
Closed
30
Calls
$1.48M
Puts
$1.12M
Net Calls
+$359K
Net Calls Change
+$1.1M
Top Buyers
| 1 |
BlackRock
New York
|
+$39.2M |
| 2 |
KAM
Krensavage Asset Management
New York
|
+$10.3M |
| 3 |
Millennium Management
New York
|
+$5.72M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.26M |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$2.73M |
Top Sellers
| 1 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$6.78M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$5.12M |
| 3 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$4.76M |
| 4 |
TA
Teachers Advisors
New York
|
-$4.6M |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$3.85M |
